Effects of Su Jok Therapy on Dyspnea and Fatigue in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Dyspnea
研究概览
简要总结
As the disease progresses, dyspnea and fatigue may increasingly interfere with daily activities, reduce patients' independence, and negatively affect their quality of life. Therefore, in addition to pharmacological treatment, there is a need for safe and supportive interventions to help alleviate these symptoms. This study aims to evaluate the effects of Su Jok therapy on dyspnea and fatigue in patients with chronic obstructive pulmonary disease (COPD). The findings are expected to provide evidence regarding the potential role of Su Jok therapy as a complementary intervention for symptom management. The results may contribute to improving patients' symptom control and quality of life while providing healthcare professionals with evidence to support clinical decision-making and nursing care.
详细描述
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disease characterized by persistent airflow limitation and symptoms such as dyspnea and fatigue, which substantially impair patients' functional capacity and quality of life. Although pharmacological treatment is the cornerstone of COPD management, complementary non-pharmacological interventions may provide additional benefits in symptom control.
Su Jok therapy is a complementary therapy based on the stimulation of corresponding points on the hands and feet. It has been proposed as a simple, non-invasive, and low-cost intervention that may help reduce symptom severity and improve patient well-being. However, evidence regarding its effectiveness in patients with COPD is limited.
This study is designed as a randomized controlled trial to evaluate the effects of Su Jok therapy on dyspnea and fatigue in patients with COPD. Eligible participants will be randomly assigned to either an intervention group receiving Su Jok therapy in addition to routine care or a control group receiving routine care alone. Dyspnea and fatigue will be assessed using validated measurement instruments before and after the intervention. The primary objective is to determine whether Su Jok therapy provides additional benefits in reducing dyspnea and fatigue compared with routine care alone. The findings are expected to contribute to the evidence base regarding complementary therapies in COPD management and to support evidence-based nursing practice.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults aged 18 years or older.
- •Diagnosed with chronic obstructive pulmonary disease (COPD).
- •Able to communicate verbally.
- •Expected to remain hospitalized for at least 5 days to ensure completion of the intervention.
- •No major health condition other than COPD that could adversely affect activities of daily living (e.g., open wounds, cancer, or gastrointestinal disorders).
- •Provided written informed consent to participate in the study.
- •A Visual Analog Scale (VAS) score of 3 or higher for dyspnea and fatigue.
排除标准
- •Declined or were unable to provide written informed consent.
- •Unable to communicate verbally.
- •Conditions preventing the application of Su Jok therapy to the hands, including neuropathy, amputation, open wounds, or other hand disorders.
研究组 & 干预措施
Su Jok Therapy Group
Participants in this group will receive routine COPD care plus five consecutive daily sessions of Su Jok therapy. Dyspnea and fatigue symptoms will be assessed daily using the Visual Analog Scale (VAS). Questionnaire data will be collected before the intervention (baseline) and after completion of the intervention (post-test).
干预措施: Su Jok Therapy (Other)
Control Group
Participants in this group will receive routine COPD care only. Dyspnea and fatigue symptoms will be assessed daily for five consecutive days using the Visual Analog Scale (VAS). Questionnaire data will be collected at baseline and after the study period (post-test).
结局指标
主要结局
Dyspnea
时间窗: Baseline and daily for 5 consecutive days, with post-intervention assessment on Day 5.
Dyspnea severity will be assessed using the Visual Analog Scale (VAS). Higher scores indicate greater dyspnea severity.
次要结局
- fatigue severity(Baseline and post-intervention (Day 5).)
研究者
Sebahat ATALIKOĞLU BAŞKAN
Assistant Professor
Erzincan Binali Yildirim Universitesi